Evogene Ltd.

Equities

EVGN

IL0011050551

Biotechnology & Medical Research

Delayed TEL AVIV STOCK EXCHANGE Other stock markets 03:37:35 26/06/2024 pm IST			5-day change	1st Jan Change
238.5 ^ILa	+2.76%		-0.29%	-20.45%

23/05	Earnings Flash (EVGN) EVOGENE Posts Q1 Revenue $4.2M, vs. Street Est of $3.5M	MT
23/05	Evogene Ltd. Provides Revenue Guidance for the Year 2024	CI

Evogene Ltd. Provides Revenue Guidance for the Year 2024

May 23, 2024 at 06:30 pm IST

Evogene Ltd. provided revenue guidance for the year 2024. For the year, the company anticipates continued revenue growth compared to the previous year, mainly in the second half of 2024 based on Casterra's forecast for seed-order supply.

Latest news about Evogene Ltd.

Earnings Flash (EVGN) EVOGENE Posts Q1 Revenue $4.2M, vs. Street Est of $3.5M	23/05	MT
Evogene Ltd. Provides Revenue Guidance for the Year 2024	23/05	CI
Transcript : Evogene Ltd., Q1 2024 Earnings Call, May 23, 2024	23/05
Evogene Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	23/05	CI
Evogene Ltd. and The Kitchen FoodTech Hub Establishes Finally Foods Ltd	02/04	CI
Evogene Receives Minimum Bid Price Non-Compliance Notice From Nasdaq	20/03	MT
Transcript : Evogene Ltd., Q4 2023 Earnings Call, Mar 07, 2024	07/03
Evogene Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	07/03	CI
Evogene Ltd. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	07/03	CI
Evogene Unit, Corteva Agriscience Identify New Potential Class of Herbicidal Molecules	06/03	MT
AgPlenus Achieves Milestone in Collaboration with Corteva to Develop Novel Herbicides	06/03	CI
Casterra Announces New Agreements with Subsidiary of Evogen Ltd., to Meet Growing Demand for Its Elite Castor Seed Varieties	05/03	CI
Evogene Files $200 Million Mixed Shelf	01/03	MT
Evogene Ltd. and Verb Biotics LLC Enters into Collaboration Agreement	06/02	CI
Casterra Ag Ltd., a subsidiary of Evogene Ltd Announces Executive Changes, Effective January 1, 2024	19/12	CI
Transcript : Evogene Ltd., Q3 2023 Earnings Call, Nov 15, 2023	15/11
Earnings Flash (EVGN) EVOGENE Posts Q3 Revenue $3.8M	15/11	MT
Evogene Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	15/11	CI
Colors Farm Ltd, Evogene Ltd. and Ben-Gurion University Collaborate to Establish Crustacean Gene Editing Technology	31/23/31	CI
Alliance Global Starts Evogene at Buy With $1.85 Price Target	02/23/02	MT
Lake Street Adjusts Evogene's Price Target to $3 From $2, Keeps Buy Rating	18/23/18	MT
Transcript : Evogene Ltd., Q2 2023 Earnings Call, Aug 17, 2023	17/23/17
Earnings Flash (EVGN) EVOGENE Posts Q2 Revenue $654,000	17/23/17	MT
Evogene Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	17/23/17	CI
Evogene Ltd 's ChemPass AI Tech-Engine is Introduces with New Breakthrough Machine Learning Technology for Target-Protein Discovery	25/23/25	CI

Chart Evogene Ltd.

Duration

Period

More charts

Company Profile

Evogene Ltd is an Israel-based company, engaged in leveraging computational biology to design products for life-science-based industries including human health, agriculture, and industrial applications. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.

Sector

Biotechnology & Medical Research

Calendar

07/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
EVOGENE LTD.	-20.45%	3.14Cr
MODERNA, INC.	+38.36%	5.27TCr
LONZA GROUP AG	+39.64%	3.9TCr
IQVIA HOLDINGS INC.	-8.63%	3.85TCr
ALNYLAM PHARMACEUTICALS, INC.	+25.46%	3.04TCr
CELLTRION, INC.	-11.17%	2.64TCr
ICON PUBLIC LIMITED COMPANY	+11.44%	2.61TCr
UNITED THERAPEUTICS CORPORATION	+45.09%	1.42TCr
MEDPACE HOLDINGS, INC.	+32.93%	1.26TCr
BIO-TECHNE CORPORATION	-5.30%	1.15TCr

Other Biotechnology & Medical Research